Imeglimin 1000 mg Tablet – IMEGLIMON 1000 | New Antidiabetic from Steris Healthcare

Introduction

Imeglimin 1000 mg is an innovative, next-generation oral antidiabetic agent that represents a new class of glucose-lowering drugs known as Glimins. It offers a unique dual mechanism to control blood sugar levels in patients with Type 2 Diabetes Mellitus (T2DM) by targeting both insulin resistance and insulin secretion. IMEGLIMON 1000 by Steris Healthcare Pvt Ltd delivers advanced glycemic control, especially for patients requiring combination therapy or who are inadequately controlled with metformin.

What is Imeglimin 1000 mg?

Imeglimin Hydrochloride 1000 mg is the first-in-class Glimin molecule that acts on mitochondrial bioenergetics to restore glucose metabolism. It is approved for improving glycemic control in adults with type 2 diabetes and is often combined with other oral antidiabetic agents or insulin.

Imeglimin 1000 mg Uses

IMEGLIMON 1000 is used for:

• Type 2 Diabetes Mellitus in adults

• Patients who are uncontrolled on metformin, sulfonylureas, DPP-4 inhibitors, or SGLT2 inhibitors

• Combination therapy or monotherapy when traditional medications are not effective

• Individuals needing a novel mechanism to improve insulin sensitivity and beta-cell function

 Not intended for Type 1 diabetes or diabetic ketoacidosis.

Mechanism of Action: How Imeglimin Works

Imeglimin acts at the mitochondrial level to improve cellular energy and glucose metabolism. It works by:

1. Enhancing insulin secretion from pancreatic beta-cells

2. Reducing insulin resistance in peripheral tissues

3. Decreasing hepatic glucose production

This triple-action mechanism sets imeglimin apart from traditional antidiabetic agents.

Dosage and Administration

• Standard dose: One tablet of imeglimin 1000 mg twice daily (usually after meals)

• Dosage may be adjusted based on blood glucose response

• No dose adjustment required in mild to moderate renal impairment

Always follow your physician’s advice and regular blood sugar monitoring.

Benefits of IMEGLIMON 1000 (Imeglimin 1000 mg Tablet)

• Novel dual-acting glucose-lowering agent

• Improves both insulin sensitivity and secretion

• Weight-neutral

• Can be safely combined with metformin, sulfonylureas, or insulin

• Well-tolerated with low hypoglycemia risk

• Manufactured under WHO-GMP certified facilities

Imeglimin Side Effects

Most patients tolerate imeglimin tablets well. However, possible side effects may include:

Common Side Effects:

• Nausea

• Diarrhea

• Headache

• Abdominal discomfort

Rare But Serious:

• Lactic acidosis (extremely rare)

• Allergic skin reactions

• Liver enzyme elevation (mild)

If any severe reaction occurs, seek medical attention immediately.

Precautions and Warnings

• Not recommended in type 1 diabetes or pregnant/breastfeeding women

• Use with caution in severe liver or renal impairment

• Regular monitoring of blood sugar, HbA1c, and liver function is advised

• Avoid alcohol intake while on treatment

Drug Interactions

• Can be safely combined with most oral antidiabetic drugs

• May enhance the hypoglycemic effect of insulin or sulfonylureas

• Minimal interaction with CYP450 enzymes

Imeglimin 1000 mg Price in India

The imeglimin 1000 mg price depends on region, brand, and pack size. IMEGLIMON 1000 offers an affordable option with high quality, enabling advanced diabetes therapy accessible to Indian patients.

For distributor pricing, bulk orders, or franchise inquiries, contact Steris Healthcare Pvt Ltd.

Why Choose IMEGLIMON 1000 from Steris Healthcare Pvt Ltd?

• Made in WHO-GMP & ISO certified manufacturing units

• Complies with strict quality and purity standards

• Trusted by doctors for novel diabetes therapy

• Ethical pricing with pan-India availability

• Backed by Steris Healthcare’s strong pharmaceutical portfolio

FAQs – Imeglimin 1000 mg Tablet (IMEGLIMON 1000)

Q1: What is imeglimin 1000 mg used for?

A: It is used to lower blood sugar levels in adults with type 2 diabetes, particularly when other drugs are insufficient.

Q2: How is imeglimin different from metformin?

A: While both target insulin resistance, imeglimin also boosts insulin secretion, offering a dual benefit.

Q3: What is the dosage of imeglimin?

A: Standard dosage is 1000 mg twice daily, usually after meals.

Q4: Is imeglimin 1000 safe in kidney patients?

A: Yes, mild to moderate renal impairment does not require dose adjustment. Severe cases should consult a specialist.

Q5: Can imeglimin cause weight gain?

A: No, it is generally considered weight-neutral.

Conclusion

IMEGLIMON 1000, containing imeglimin 1000 mg, is an advanced and effective treatment for type 2 diabetes, ideal for patients who need a new therapeutic approach. With its dual mechanism and excellent safety profile, IMEGLIMON 1000 by Steris Healthcare Pvt Ltd offers a modern solution for improved glucose control and metabolic health.